SCHEMBL14747480

SCHEMBL14747480

COC(=O)c1c(NC(=O)c2ccccc2)cnn1-c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.54
RAB9A P51151 4/20 0.48
HTT P42858 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
MAPK14 Q16539 1/20 0.47
TSHR P16473 1/20 0.47
NPC1 O15118 2/20 0.47
PKM P14618 1/20 0.47
GAA P10253 2/20 0.47
MAPK1 P28482 2/20 0.47
KDM4E B2RXH2 1/20 0.47
HSD17B10 Q99714 1/20 0.47
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
CYP1A2 P05177 1/20 0.46
POLB P06746 1/20 0.46
CYP2C9 P11712 1/20 0.46
HPGD P15428 1/20 0.46
LMNA P02545 1/20 0.46
ATM Q13315 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12998034 0.86 ALDH1A1 (0.49) ALDH1A1RAB9AMAPK14TSHRNPC1
SCHEMBL13688102 0.82 RAB9A (0.54) ALDH1A1RAB9AHTTMAPK14NPC1
SCHEMBL18134653 0.81 RAB9A (0.61) ALDH1A1RAB9ATSHRNPC1PKM
SCHEMBL71048 0.77 ALDH1A1 (0.56) ALDH1A1RAB9ANPC1PKMGAA
SCHEMBL13055154 0.76 ALDH1A1 (0.47) ALDH1A1RAB9AMAPK14TSHRNPC1
SCHEMBL13688122 0.75 RAB9A (0.57) ALDH1A1RAB9AHTTMAPK14TSHR
SCHEMBL14946275 0.75 RAB9A (0.51) ALDH1A1RAB9AHTTNPC1HSD17B10
SCHEMBL33206 0.74 RAB9A (0.56) ALDH1A1RAB9AHTTTSHRNPC1
SCHEMBL13688142 0.74 RAB9A (0.57) ALDH1A1RAB9AHTTTSHRNPC1
SCHEMBL12998027 0.72 TDP1 (0.48) ALDH1A1RAB9ANPC1PKMGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130123265-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA, INC. (US) 2013-05-16 US disclosed
US-8389567-B2 Compounds that modulate intracellular calcium CALCIMEDICA, INC. (US) 2013-03-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130123265-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, ATP2A1 ALDH1A1 4373/4885RAB9A 1003/4885HTT 702/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.